Chemed

Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment includes plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is headquartered in Cincinnati, OH.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Chemed exceeds earnings expectations, focuses on strategic growth initiatives

Chemed's strong financial performance in 2022 was supported by targeted hiring and retention efforts.
Both VITAS and Roto-Rooter are focusing on improving staffing and revenue growth.
Chemed's strategic initiatives position the company well for future growth and operational efficiency.
The company's emphasis on culture and strategic approaches enhances valuation in the M&A market.

Chemed reports strong Q1 performance, optimistic about growth trajectory

Chemed's Q1 2023 earnings call highlighted a positive performance trajectory post-pandemic, with a focus on VITAS' growth and operational strategies. The company addressed challenges related to Medicare reimbursement rates and emphasized opportunities for further expansion and staff satisfaction.

Chemed's VITAS shines, Roto-Rooter adapts to consumer challenges

Chemed's Q2 2023 earnings call highlighted VITAS' strong performance and operational improvements post-pandemic.
Roto-Rooter faced challenges in consumer spending but focused on enhancing online presence and conversion rates.
Both segments showcased resilience amidst economic headwinds, with strategic initiatives in place to drive growth and operational efficiency.
Chemed's strategic cost management and revenue generation strategies position the company for sustainable growth and margin protection.

Chemed reports strong Q3 performance, eyes growth amid economic challenges

Chemed's diversified business segments showed resilience and growth potential, with VITAS Healthcare and Roto-Rooter both demonstrating strengths and addressing challenges. The company remains cautiously optimistic about 2024, focusing on operational efficiency and market dynamics for sustained performance.

Chemed's VITAS shines in Q4 with strong growth, Roto-Rooter faces challenges

Chemed's VITAS segment excelled with strong revenue growth and operational improvements, while Roto-Rooter faced challenges in call volume.
Management's confidence in sustained growth and margin improvement presents opportunities for both VITAS and Roto-Rooter in 2024.
Strategies to address challenges and capitalize on opportunities will be crucial for Chemed's divisions to meet their forecasted targets.
Overall, Chemed's performance in Q4 2023 sets a positive tone for the company's outlook and strategic initiatives moving forward.

Chemed excels in hospice segment, Roto-Rooter faces commercial challenges

Chemed's VITAS segment outperformed, while Roto-Rooter faced challenges, prompting strategic actions to enhance commercial performance and drive growth.

Chemed's VITAS shines in Q2 2024, Roto-Rooter faces revenue challenges

Chemed's VITAS segment is driving revenue growth and margin expansion, while Roto-Rooter faces challenges in revenue decline. The company aims to capitalize on growth opportunities in the hospice services sector.

Chemed's VITAS shines amid Roto-Rooter's challenges in Q3 2024

Chemed's earnings call showcased VITAS' resilience and growth prospects, while addressing Roto-Rooter's challenges and strategic adjustments. The company remains optimistic about adjusted net income outlook for the year.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Chemed provides exposure to two very different divisions: Hospice care and plumbing. The share price recently fell by over 20% as the market was getting a little bit ahead of itself.

Despite Its Non-Recurring Income In 2020, Chemed Remains Attractive

Chemed's (CHE) CEO Kevin McNamara on Q4 2020 Results - Earnings Call Transcript

Chemed's (CHE) fourth-quarter 2020 revenues increased 2.1% year over year to $533.3 million.

Chemed (CHE) Q4 Earnings Miss Estimates, 2021 Outlook Dull

Shares of Chemed (NYSE:CHE) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 21.56% over the past year to $5.13, which were in line with the estimate of $5.13.

Recap: Chemed Q4 Earnings

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2020, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 2.1% to $533 million GAAP D

Chemed Reports Fourth-Quarter 2020 Results

Abbott Labs

Allstate

Leidos Hld

Westlake Chemical

The Allstate board of directors has approved a quarterly dividend of $0.81 cents on each outstanding share of the corporation's common stock, payable in cash on April 1, 2021, to stockholders of record at the close of business on March 4, 2021. This represents a 50% increase from the dividend declared in the previous quarter.

Daily Dividend Report: Allstate, Abbott, Westlake Chemical, Chemed, Leidos Holdings

Chemed (NYSE:CHE) releases its next round of earnings this Tuesday, February 23. Here is Benzinga's essential guide to Chemed's Q4 earnings report.

Earnings Preview: Chemed

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 34-cents per share on the Company's capital stock, payable on March 19, 2021, to shareholders of record as of March 1, 2021. This is equal to the dividend paid in December 2020. This represents the 199th consecutive quarterly dividend paid by Chemed in its 49 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinna

Chemed Corporation Declares Quarterly Dividend of 34 Cents

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2020, on Tuesday, February 23, 2021, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Wednesday, February 24, 2021, to discuss the company's quarterly results and to provide an update on its business. The toll-free dial-in number for the conference call is 844-74

Chemed To Report Fourth-Quarter 2020 Earnings February 23, Related Conference Call To Be Held On February 24

DaVita

U.S. Physical Therapy

3 Outpatient Home Health Stocks Set to Ride the Industry's Upturn

Chemed (CHE) possesses solid growth attributes, which could help it handily outperform the market.

Looking for a Growth Stock? 3 Reasons Why Chemed (CHE) is a Solid Choice

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Credit Suisse 29th Annual Virtual Healthcare Conference on Tuesday, November 10, 2020, at approximately 12:30 p.m. (ET). The presentation will be webcast live and can be accessed through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 48 hours after the live presentation and will be accessible for one year. Listed on the New

Chemed Corporation to Present at the 2020 Credit Suisse Virtual Healthcare Conference

Chemed (CHE) could produce exceptional returns because of its solid growth attributes.

Is Chemed (CHE) a Solid Growth Stock? 3 Reasons to Think " Yes "

Chemed (CHE) reports solid revenue growth across key subsidiaries in third-quarter results.

Chemed's (CHE) Shares Up on Q3 Earnings and Revenue Beat

Chemed Corporation (CHE) CEO Kevin McNamara on Q3 2020 Results - Earnings Call Transcript

Chemed (CHE) delivered earnings and revenue surprises of 21.80% and 2.17%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Chemed (CHE) Beats Q3 Earnings and Revenue Estimates

Shares of Chemed (NYSE:CHE) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 40.46% year over year to $4.86, which beat the estimate of $3.97.

Chemed: Q3 Earnings Insights

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2020, versus the comparable prior-year period, as follows: Consolidated operating results: Revenue increased 9.9% to $528 million GAAP Di

Chemed Reports Third-Quarter 2020 Results

Charles River Laboratories

Novocure

Universal Health Services

Coronavirus is going to affect the earnings results of healthcare players. While hospitals and health insurers might have suffered the COVID-19 impact, others providing virtual care and COVID-19-related services are likely to have gained from the same.

Healthcare Stock Q3 Earnings Due on Oct 29: NVCR, CRL & More

Chemed (CHE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Chemed (CHE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the third quarter ended September 30, 2020, on Thursday, October 29, 2020, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Friday, October 30, 2020, to discuss the company's quarterly results and to provide an update on its business. The toll-free dial-in number for the conference call is 844-743-25

Chemed To Report Third-Quarter 2020 Earnings October 29, Related Conference Call To Be Held On October 30

AmerisourceBergen

Neogen

Novo Nordisk

ResMed

As the world grapples with an unprecedented coronavirus pandemic, five health care stocks that have outperformed the Standard & Poor's 500 Index by at least 5% in the year to date are AmerisourceBergen Corp. (NYSE:ABC), Chemed Corp. (NYSE:CHE), Neogen Corp. (NASDAQ:NEOG), Novo Nordisk A/S (NYSE:NVO) and ResMed Inc. (NYSE:RMD) according to the All-in-One Screener, a Premium feature of GuruFocus.

5 Health Care Stocks Outperforming the S&P 500

Chemed (CHE) reported earnings 30 days ago. What's next for the stock?

Why Is Chemed (CHE) Up 2.9% Since Last Earnings Report?

Hillenbrand

Jack Henry & Associates

Keurig Dr Pepper Inc

Ubiquiti Inc

Markets are looking for some direction today with the Dow lower, the S&P flat, and the Nasdaq higher. Some optimism is shown on the economic side today with durable goods orders rising 11.2% in July, smashing expectations.

Best Stocks To Buy Today As Markets Aim For New Record Highs

Chemed shows rising price performance, earning an upgrade to its IBD Relative Strength Rating
The post Stocks Generating Improved Relative Strength: Chemed appeared first on Investor's Business Daily.

News for Chemed Stock (CHE)